Dr. Esquenazi Levy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6400 Fannin St
Ste 2800
Houston, TX 77030Phone+1 713-486-8000Fax+1 713-486-8088
Education & Training
- University of Texas Health Science Center at HoustonResidency, Neurological Surgery, 2009 - 2015
- Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2008 - 2009
- Universidad Anahuac School of MedicineClass of 2007
Certifications & Licensure
- TX State Medical License 2016 - 2025
- NY State Medical License 2015 - 2017
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Houstonia Top Doctors Neurosurgery 2018
- AOA-Spine 2015
- Resident Award Alpha Omega Alpha Honor Medical Society Delta Chapter, 2014
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsIncreased Risk of Subsequent Meningioma Among Women with Malignant Breast Cancer.Victor Lopez-Rivera, Ping Zhu, Antonio Dono, Songmi Lee, Peng R Chen
World Neurosurgery. 2020-04-13 - 28 citationsEGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma.Koos E. Hovinga, Heather J. McCrea, Cameron Brennan, Jason T. Huse, Junting Zheng
Journal of Neuro-Oncology. 2019-01-24 - 13 citationsIDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas.Yoko Fujita, Luis Nunez-Rubiano, Antonio Dono, Allison Bellman, Mauli Shah
Journal of Neuro-Oncology. 2022-09-01
Journal Articles
- EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastomaHovinga KE, McCrea HJ, Brennan C, Huse J, Zheng J, Esquenazi Y, Panageas KS, Tabar V, J Neurooncol, 1/24/2019
- Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent GlioblastomaMorris SA, Zhu P, Rao M, Zhu JJ, Hsu S, Ballester LY, Day AL, Tandon N, Kim DH, Shephard S, Blanco AI, Esquenazi Y, World Neurosurgery, 1/1/2019
- Telomerase Reverse Transcriptase (TERT) alterations in Human Cancers; Diagnosis, Prognosis and Therapeutic ImplicationsEsquenazi Y, Ballester LY, Cancer Cytopathology, 1/1/2019
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Differentiating Abscess from Necrosis by ADC value measurement.Kamali A, Doyle N, Rabiei P, Lugo A, Zhu JJ, Esquenazi Y, Patel R, Riascos R, ASNR 57th Annual Meeting, Boston, MA, 1/1/2019
- Access to clinical trials, multidisciplinary environment, and health care providers by facility type and outcomes of patients with newly diagnosed glioblastoma using t...Zhu P, Du X, Esquenazi Y, Zhu J, ASCO, Chicago, IL, 1/1/2019
- Impact of Travel Distance to Care Facility on Survival in Patients with Glioblastoma: A Retrospective Study Using the National Cancer Database.Zhu P, Du X, Esquenazi Y, Zhu J, American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, 1/1/2019
- Join now to see all
Lectures
- The 2016 World Health Organization Classification of Tumors of the Central Nervous SystemGuadalajara, Mexico, 2018; Hotel RIU, Guadalajara, Mexico, 2019 - 1/26/2019
- Neurosurgical Emergencies � Imaging findings and managementHotel RIU, Guadalajara, Mexico - 1/26/2019
- Feasibility of a Liquid Biopsy assay in CNS tumors.Memorial Sloan Kettering Cancer Center, Rockefeller Research Institute, New York, NY - 1/25/2019
- Join now to see all
Other
- Hydrocephalus (Water in the brain). (Media Appearance)Esquenazi Y, Univision: afternoon news network, Channel 45
Houston, TX - 1/1/2017 - Laser treatment for brain tumors. (Media Appearance)Esquenazi Y, Univision: Special Health report, Channel 45
1/1/2017 - Primary and secondary brain tumors. (Media Appearance)Esquenazi Y, Univision: morning news network, Channel 45
Houston, TX - 1/1/2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: